Qura offers an integrated hybrid care pathway that begins with comprehensive blood testing via partner laboratories, followed by AI-driven analysis and a 45-minute consultation with a dedicated physician. The service targets the millions of Europeans experiencing persistent subclinical symptoms such as chronic fatigue, hormonal imbalances, digestive issues, and unexplained hair loss. Each member receives a personalized health plan that outlines immediate actions and longer-term monitoring, supported by ongoing medical guidance. The company keeps physicians at the center while leveraging AI to increase efficiency, personalization, and patient adherence. Its EU-native platform is GDPR-compliant, medically validated, and connected to local lab networks to ensure regulatory alignment. Fresh capital will be used to expand hiring across medical, engineering, and operations teams, invest in digital marketing and community-led growth, enhance AI health-intelligence capabilities, and prepare for expansion into additional European markets.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2026